Previous close | 46.87 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 0.23 |
EPS (TTM) | 2.22 |
Earnings date | 02 Aug 2023 - 07 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 24.73% and 3.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Corteva (CTVA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corteva, Inc. (CTVA) closed the most recent trading day at $61.51, moving +0.05% from the previous trading session.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Archer Daniels Midland, Corteva, Adecoagro and Limoneira have been highlighted in this Industry Outlook article.
Raw material and commodity price inflation, along with tight supply conditions, is expected to mar the Agriculture - Operations industry in the near term. Companies like ADM, CTVA, AGRO and LMNR look poised to gain on solid product portfolios and innovation.
Corteva, Inc. (CTVA) closed at $61 in the latest trading session, marking a +1.14% move from the prior day.
PacBio (PACB), in collaboration with Corteva Agriscience, is likely to enable groundbreaking plant and microbial long-read sequencing workflow on Revio system.
Corteva, Inc. (CTVA) closed at $58.10 in the latest trading session, marking a +0.69% move from the prior day.
Corteva, Inc. (CTVA) closed at $57.44 in the latest trading session, marking a -1.83% move from the prior day.
Bunge (BG) collaborates with Corteva and Chevron to produce winter canola hybrids and boost supply of vegetable oil feedstocks.
INDIANAPOLIS, ST. LOUIS, & SAN RAMON, Calif., March 14, 2023--Corteva Inc. (NYSE: CTVA), Bunge (NYSE:BG) and Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), announced today a commercial collaboration to introduce proprietary winter canola hybrids that produce plant-based oil with a lower carbon profile. The goal is to increase the availability of vegetable oil feedstocks primarily for the growing domestic renewable fuels market. The companies plan to introduce the winter ca
Buy high and sell higher. These stocks have all significantly outperformed the market over the last year.
According to the average brokerage recommendation (ABR), one should invest in Corteva, Inc. (CTVA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Rather, the market believes that over the next few years, the seed and crop protection company will perform excellently, thus assigning premium multiples to its stock. Here's why Corteva is on a long-term growth trajectory. Based on Wall Street analyst consensus estimates, Corteva is set to significantly improve its earnings and free cash flow (FCF) in the coming years.
An agriscience company, an instrumentation technology company, and an aerospace and defense giant all qualify as outstanding stocks.
These three stocks have declined over the last six months, and it's time to think about buying them.
By Davit Kirakosyan
The average brokerage recommendation (ABR) for Corteva, Inc. (CTVA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 166.67% and 0.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?